Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists

Phillip M Cowley, James Baker, Kirsteen I Buchanan, Ian Carlyle, John K Clark, Thomas R Clarkson, Maureen Deehan, Darren Edwards, Yasuko Kiyoi, Iain Martin, Dawn Osbourn, Glenn Walker, Nick Ward, Grant Wishart

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


The pharmacokinetic based optimisation of a novel series of indole-2-carboxamide antagonists of the cannabinoid CB(1) receptor is disclosed. Compound 24 was found to be a highly potent and selective cannabinoid CB(1) antagonist with high predicted human oral bioavailability.

Original languageEnglish
Pages (from-to)2034-2039
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Issue number7
Publication statusPublished - 1 Apr 2011


  • administration, oral
  • biological availability
  • humans
  • indoles
  • receptor, Cannabinoid, CB1
  • structure-activity relationships


Dive into the research topics of 'Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists'. Together they form a unique fingerprint.

Cite this